Filing Details
- Accession Number:
- 0001209191-17-007221
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-02 17:43:34
- Reporting Period:
- 2017-02-01
- Filing Date:
- 2017-02-02
- Accepted Time:
- 2017-02-02 17:43:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1401667 | Puma Biotechnology Inc. | PBYI | Pharmaceutical Preparations (2834) | 770683487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1678610 | Robert Charnas | C/O Puma Biotechnology, Inc. 10880 Wilshire Boulevard, Suite 2150 Los Angeles CA 90024 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-02-01 | 1,000 | $31.80 | 28,461 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-01 | 2,008 | $31.85 | 26,453 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 15, 2016.
Billionaire Hedge Funds
